Neuroscience

Targeted panel testing superior for neuromuscular diseases

(HealthDay)—Targeted panel testing has the highest clinical yield for molecular diagnosis of neuromuscular diseases (NMDs), according to a study published in the February issue of the Annals of Neurology.

Alzheimer's disease & dementia

Seizures late in life may be an early sign of Alzheimer's disease

Patients with epilepsy who had amnestic mild cognitive impairment (aMCI) or Alzheimer disease (AD) presented earlier with cognitive decline than patients who did not have epilepsy, according to a report published by JAMA ...

Alzheimer's disease & dementia

First Alzheimer's case has full diagnosis 106 years later

(Medical Xpress)—More than a hundred years after Alois Alzheimer identified Alzheimer's disease in a patient an analysis of that original patient's brain has revealed the genetic origin of their condition.

page 1 from 2